Literature DB >> 3546388

Major histocompatibility complex class II antigen expression in B and T cell non-Hodgkin's lymphoma.

M E Smith, C S Holgate, J M Williamson, I Grigor, P Quirke, C C Bird.   

Abstract

An immunohistochemical study of 46 B and T cell non-Hodgkin's lymphomas, using monoclonal antibodies to the products of the major histocompatibility complex (MHC) class II antigen subregions, DP, DQ, and DR, showed that most B and T cell lymphomas express these antigens. Both coordinate and non-coordinate expression of MHC class II antigens was observed, but this did not correlate with immunological phenotype, morphological grade, or proliferation index as determined by flow cytometry.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3546388      PMCID： PMC1140825          DOI： 10.1136/jcp.40.1.34

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN： 0021-9746            Impact factor:   3.411


  22 in total

1.  The modulation of membrane Ia on human B lymphocytes.

Authors:  J H Kehrl; A Muraguchi; A S Fauci
Journal:  Cell Immunol       Date:  1985-05       Impact factor: 4.868

2.  Immunophenotypic differences between dermatopathic lymphadenopathy and lymph node involvement in mycosis fungoides.

Authors:  L M Weiss; G S Wood; R A Warnke
Journal:  Am J Pathol       Date:  1985-08       Impact factor: 4.307

3.  Differential expression and serologically distinct subpopulations of human Ia antigens detected with monoclonal antibodies to Ia alpha and beta chains.

Authors:  K Guy; V Van Heyningen; B B Cohen; D L Deane; C M Steel
Journal:  Eur J Immunol       Date:  1982-11       Impact factor: 5.532

4.  Ia determinants on human T-cell subsets defined by monoclonal antibody. Activation stimuli required for expression.

Authors:  E L Reinherz; P C Kung; J M Pesando; J Ritz; G Goldstein; S F Schlossman
Journal:  J Exp Med       Date:  1979-12-01       Impact factor: 14.307

5.  Human MHC class II molecules as differentiation markers.

Authors:  V van Heyningen; K Guy; R Newman; C M Steel
Journal:  Immunogenetics       Date:  1982       Impact factor: 2.846

6.  HLA-DR synthesis induction and expression in HLA-DR-negative carcinoma cell lines of diverse origins by interferon-gamma but not by interferon-beta.

Authors:  A R Shaw; J K Chan; S Reid; J Seehafer
Journal:  J Natl Cancer Inst       Date:  1985-06       Impact factor: 13.506

7.  The expression of major histocompatibility antigens by human chorionic villi.

Authors:  C A Sunderland; M Naiem; D Y Mason; C W Redman; G M Stirrat
Journal:  J Reprod Immunol       Date:  1981-12       Impact factor: 4.054

Review 8.  Expression of MHC class II antigens in human B-cell leukaemia and non-Hodgkin's lymphoma.

Authors:  K Guy; A S Krajewski; A E Dewar
Journal:  Br J Cancer       Date:  1986-02       Impact factor: 7.640

9.  DNA aneuploidy in colorectal adenomas.

Authors:  P Quirke; J B Fozard; M F Dixon; J E Dyson; G R Giles; C C Bird
Journal:  Br J Cancer       Date:  1986-04       Impact factor: 7.640

10.  IL-2-mediated T cell proliferation in humans is blocked by a monoclonal antibody directed against monomorphic determinants of HLA-DR antigens.

Authors:  A Moretta; R S Accolla; J C Cerottini
Journal:  J Exp Med       Date:  1982-02-01       Impact factor: 14.307
View more
  8 in total

1.  Glomeruloid microvascular proliferation follows adenoviral vascular permeability factor/vascular endothelial growth factor-164 gene delivery.

Authors:  C Sundberg; J A Nagy; L F Brown; D Feng; I A Eckelhoefer; E J Manseau; A M Dvorak; H F Dvorak
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

2.  White pulp reconstitution after human bone marrow transplantation.

Authors:  A Nakayama; N Hirabayashi; M Ito; K Kasai; M Fujino; M Ohbayashi; J Asai
Journal:  Am J Pathol       Date:  1993-10       Impact factor: 4.307

3.  HLA antigen expression in enteropathy associated T cell lymphoma.

Authors:  M Ashton-Key; N Singh; L X Pan; M E Smith
Journal:  J Clin Pathol       Date:  1996-07       Impact factor: 3.411

4.  Immunohistological and electron microscopical study of nodular fasciitis of the orbit.

Authors:  T Sakamoto; T Ishibashi; Y Ohnishi; H Inomata
Journal:  Br J Ophthalmol       Date:  1991-10       Impact factor: 4.638

Review 5.  Regulation of major histocompatibility complex class II gene expression, genetic variation and disease.

Authors:  L Handunnetthi; S V Ramagopalan; G C Ebers; J C Knight
Journal:  Genes Immun       Date:  2009-11-05       Impact factor: 2.676

6.  Differential expression of MHC class II antigens in chronic B-cell disorders.

Authors:  H G Drexler; S M Gignac; M K Brenner; E Coustan-Smith; G Janossy; A V Hoffbrand
Journal:  Clin Exp Immunol       Date:  1988-02       Impact factor: 4.330

7.  The insulator factor CTCF controls MHC class II gene expression and is required for the formation of long-distance chromatin interactions.

Authors:  Parimal Majumder; Jorge A Gomez; Brian P Chadwick; Jeremy M Boss
Journal:  J Exp Med       Date:  2008-03-17       Impact factor: 14.307

8.  Expression of the Classical and Nonclassical HLA Molecules in Breast Cancer.

Authors:  Gisela Bevilacqua Rolfsen Ferreira da Silva; Tarsia Giabardo Alves Silva; Roberta Aparecida Duarte; Nicolino Lia Neto; Hélio Humberto Angotti Carrara; Eduardo Antônio Donadi; Maria Alice Guimarães Gonçalves; Edson Garcia Soares; Christiane Pienna Soares
Journal:  Int J Breast Cancer       Date:  2013-12-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.